Biopharma
-
CSL Names Interim CEO After McKenzie’s Departure
Australian biopharmaceutical giant CSL has appointed Gordon Naylor as interim CEO and managing director, following the immediate departure of Paul McKenzie. The leadership change comes as the company navigates a significant strategic transformation and faces scrutiny over its recent share…